RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00034924.xml
Nuklearmedizin 2018; 57(06): N57
DOI: 10.3413/Nukmed-0990-18-08
DOI: 10.3413/Nukmed-0990-18-08
Case Report
HCG-induced hyperthyroidism in a 51-year-old patient with hydatidiform mole
Weitere Informationen
Publikationsverlauf
Received:
06. August 2018
accepted:
10. Oktober 2018
Publikationsdatum:
18. Dezember 2018 (online)
![](https://www.thieme-connect.de/media/10.1055-s-00034924/201806/lookinside/thumbnails/10-3413-nukmed-0990-18-08-1.jpg)
-
References
- 1 Canfield RE, O’Connor JF, Birken S, Krichevsky A, Wilcox AJ. Development of an assay for a biomarker of pregnancy and early fetal loss. Environ Health Perspect 1987; 74: 57-66.
- 2 Ghaemmaghami F, Ashraf-Ganjooie T. Gestational trophoblastic neoplasia. Asia-Pacific Journal of Clinical Oncology 2006; 02 (01) 9-21.
- 3 Giralt S, Dexeus F, Amato R. Hyperthyroidism in men with germ cell tumours and high levels of beta-human chorionic gonadotropin. Cancer 1992; 69: 1286-1290.
- 4 Yoshimura M, Pekary AE, Pang XP, Berg L, Goodwin TM, Hershman JM. Thyrotropic activity of basic isoelectric forms of human chorionic gonadotropin extracted from hydatidiform mole tissues. J Clin Endocrinol Metab 1994; 78 (04) 862-866.